- Ab00219-1.1 Anti-CD19 [4G7]
- Mouse IgG1
- In Stock
- Ab00219-23.0 Anti-CD19 [4G7]
- Rabbit IgG
- In Stock
Recombinant monoclonal antibody to CD19. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 4G7.
UniProt Accession Number of Target Protein: P15391
Alternative Name(s) of Target: Leu12; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19 T-cell surface antigen Leu-12; CD19
Immunogen: Human CCL (chronic lymphocytic leukemia) cells.
Specificity: Recognises human CD19.
Application Notes: This antibody was used in the identification of the B-cell epitope CD19.
Antibody first published in:
Meeker et al. A unique human B lymphocyte antigen defined by a monoclonal antibody. Hybridoma. 1984 Winter;3(4):305-20. PMID:6441771
Note on publication: Describes the generation and chracterization of this antibody.
Flow-cytometry using anti-CD19 antibody 4G7 (Ab00219) Human lymphocytes were stained with an isotype control (Ab00102-23.0, panel A) or the rabbit-chimeric version of 4G7 (Ab00219-23.0, panel B) at a concentration of 1 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FACSCanto flow-cytometer.